Vasc Q Laminate Med

Laminate has developed vasq a blood vessel support device for.

Vasc q laminate med.

Value vascular access laminate european experience. Listing a study does not mean it has been evaluated by the u s. Preliminary data are presented of its use assessing its safety and efficacy for brachiocephalic avfs in haemodialysis patients. The israel based company s vasq device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure.

On january 19th laminate medical technologies announced that it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. Tel aviv israel oct. 23 2019 prnewswire the israeli start up laminate medical technologies developer of the vasq external vascular support device for arteriovenous fistulas in patients. Laminate medical technologies said today it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular.

Laminate medical technologies was founded in 2012 by tammy gilon and dr. A post market surveillance study to assess the safety and effectiveness of vasq value the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.